Literature DB >> 20628856

[Liability of surgeons with respect to injuries to the bile duct during laparoscopic cholecystectomy : Analyses of malpractice litigations in the years 1996-2009].

P T Fellmer1, J Fellmer, S Jonas.   

Abstract

BACKGROUND: Injuries to the bile duct during laparoscopic cholecystectomy are often a cause of malpractice litigations.
METHODS: A total of 13 legal verdicts as a result of bile duct injury from 1996 to 2009 were reviewed. Comments on the verdicts and the opinions of expert witnesses were analyzed.
RESULTS: Out of 13 claims, 7 were upheld and 6 were rejected. Most expert witnesses from 1996 to 2002 stated that not carrying out a cholangiography and insufficient preparation of the cystic duct constituted a performance below the standard of care expected. Expert witness testimonies from 2004 to 2009, however, regarded injury to the bile duct as predominantly inherent to treatment.
CONCLUSION: With the expansion and acceptance of laparoscopic interventions, changes in the results of malpractice litigation have become evident. In contrast to the phase during establishment of the technology, an injury to the bile duct is nowadays judged predominantly as inherent to treatment.

Entities:  

Mesh:

Year:  2011        PMID: 20628856     DOI: 10.1007/s00104-010-1954-y

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  13 in total

Review 1.  Causes and prevention of laparoscopic bile duct injuries: analysis of 252 cases from a human factors and cognitive psychology perspective.

Authors:  Lawrence W Way; Lygia Stewart; Walter Gantert; Kingsway Liu; Crystine M Lee; Karen Whang; John G Hunter
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

Review 2.  Biliary injury in laparoscopic surgery: part 1. Processes used in determination of standard of care in misidentification injuries.

Authors:  Steven M Strasberg
Journal:  J Am Coll Surg       Date:  2005-10       Impact factor: 6.113

Review 3.  Biliary injury in laparoscopic surgery: part 2. Changing the culture of cholecystectomy.

Authors:  Steven M Strasberg
Journal:  J Am Coll Surg       Date:  2005-10       Impact factor: 6.113

Review 4.  Role of intraoperative cholangiography in avoiding bile duct injury.

Authors:  Nader N Massarweh; David R Flum
Journal:  J Am Coll Surg       Date:  2007-04       Impact factor: 6.113

5.  Is damage to the common bile duct during laparoscopic cholecystectomy an inherent risk of the operation?

Authors:  Josef E Fischer
Journal:  Am J Surg       Date:  2009-06       Impact factor: 2.565

Review 6.  Error traps and vasculo-biliary injury in laparoscopic and open cholecystectomy.

Authors:  Steven M Strasberg
Journal:  J Hepatobiliary Pancreat Surg       Date:  2008-06-06

7.  [Forensic aspects of complicated laparoscopic cholecystectomy].

Authors:  A Low; D Decker; U Kania; A Hirner
Journal:  Chirurg       Date:  1997-04       Impact factor: 0.955

8.  Laparoscopic bile duct injury: understanding the psychology and heuristics of the error.

Authors:  Sidney W A Dekker; Thomas B Hugh
Journal:  ANZ J Surg       Date:  2008-12       Impact factor: 1.872

9.  Iatrogenic biliary injury: 13,305 cholecystectomies experienced by a single surgical team over more than 13 years.

Authors:  O Tantia; M Jain; S Khanna; B Sen
Journal:  Surg Endosc       Date:  2008-01-18       Impact factor: 4.584

10.  Poor agreement among expert witnesses in bile duct injury malpractice litigation: an expert panel survey.

Authors:  Philip R de Reuver; Marcel G W Dijkgraaf; Sjef K M Gevers; Dirk J Gouma
Journal:  Ann Surg       Date:  2008-11       Impact factor: 12.969

View more
  2 in total

1.  [Perception of natural orifice surgery. Results of a survey of female physicians and nursing staff].

Authors:  T Benhidjeb; C Gericke; C Spies; K Miller; A Schneider; F Müller
Journal:  Chirurg       Date:  2011-08       Impact factor: 0.955

2.  Medico-legal aspects of bile duct injury.

Authors:  Vinay Kumar Kapoor
Journal:  J Minim Access Surg       Date:  2016 Jan-Mar       Impact factor: 1.407

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.